Hyphens Pharma International Limited is a company based in Singapore. It is listed on the Catalist board of the Singapore Exchange (SGX). The company has offices in Singapore, Vietnam, Malaysia, Indonesia, and the Philippines, and its marketing and distribution network covers 10 other markets. Hyphens Pharma specializes in marketing and selling specialty pharmaceutical products in selected ASEAN countries. They do this through exclusive distributorship or licensing and supply agreements with brand principals mainly from Europe and the United States. They also develop, market, and sell their own range of dermatological products and health supplement products. In addition, Hyphens Pharma operates a medical hypermart that supplies pharmaceutical products and medical supplies to healthcare professionals, healthcare institutions, and retail pharmacies. They focus on certain therapeutic areas or medical specialties such as dermatology, paediatrics and neonatology, allergy, otorhinolaryngology, orthopaedic and rheumatology, radiology, cardiology and interventional cardiology, ophthalmology, gastroenterology, child psychiatry, and family medicine. Some of the major products in Hyphens Pharma's portfolio include contrast media products, Stérimar nasal sprays, Bausch+Lomb eye drops, VivomixxTM, Fenosup Lidose, and Piascledine. They also have their own brands, including Ceradan and TDF for dermatological products, Ocean Health for health supplements, and CG 210 for scalp care products.
Headquarters
16 Tai Seng Street, Level 4
Singapore; Singapore;
Postal Code: 534138
Contact Details: Purchase the Hyphens Pharma International Limited report to view the information.
Website: http://www.hyphens.com.sg
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service